Viramune
Viramune is designed to target HIV to mitigate viral replication, utilized to support immune system function and to address long-term viral progression.
- Category
- HIV Management
- Active ingredient
- Nevirapine
- Supply
- Rx
- Route
- Oral use
- Form
- Tablet
- Strengths
- 200mg
Viramune details
- Condition
- HIV Infection
- Therapeutic class
- Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
- Pharmacological class
- NNRTI
- Contraindications
- severe hepatic impairment; hypersensitivity to nevirapine
- Minor side effects
- nausea; headache; fatigue; rash
- Moderate side effects
- elevated liver enzymes; vomiting
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Boehringer Ingelheim
- Onset Time
- 1–4 hours
- Duration
- 24 hours
- Storage instructions
- Store at room temperature.
- Drug interactions
- rifampicin; hormonal contraceptives; st. john's wort; warfarin
- Age restrictions
- For adults and children as directed.
Precautions and warnings
monitor liver function closely; watch for signs of severe skin rash; regular blood monitoring required
Serious side effects
stevens-johnson syndrome, requires immediate medical attention; hepatitis, requires immediate medical attention
Patient summary
Viramune is designed to target HIV to mitigate viral replication, utilized to support immune system function and to address long-term viral progression.
Mechanism of action
Viramune functions as a non-nucleoside reverse transcriptase inhibitor. It binds directly to the reverse transcriptase enzyme of HIV-1, preventing the conversion of viral RNA into DNA, which effectively stops the virus from replicating.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly indicated by a specialist. Breastfeeding: Not advised due to risk of virus transmission.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Viramune
Viramune delivers the active ingredient nevirapine, a medicinal treatment for HIV infection. Produced by Boehringer Ingelheim, it comes as a 200mg tablet. This medication enables patients to access essential therapy, providing a consistent way to manage their condition within their daily health routines.
Viramune availability in Asia
Viramune is registered across 14 markets including the Philippines, Indonesia and Taiwan, with availability also extending to South Korea, Japan and the UAE. Many patients find that generic nevirapine, often manufactured in India, provides a more budget-friendly option compared to the original Boehringer Ingelheim brand. Given the nature of this therapy, it is best used under the guidance of a doctor to monitor response and maintain sustained health progress.